Neurodegenerative Disease
Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics
Published in Physician Business Week, December 16th, 2008
Transgenomic, Inc. (BULLETIN BOARD: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical's Neurodegenerative Biomarkers, which include NuroPro(R), a proposed diagnostic for Alzheimer's and Parkinson's disease. Transgenomic plans to offer NuroPro(R) in its CLIA-certified molecular diagnostics laboratory as well as support the tests with development resources.
Power3's technology assigns a probability score that reflects how closely a patient's sample fits a biostatistical model for a neurological disease (NuroPro(R)), and indicates if the patient should...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- Acuo Technologies
Acuo Technologies Announces Vendor Neutral Archiving Contract With Children's Hospital of Philadelphia - Consumers for Fair and Affordable Insurance Reform
Over 40 Hospitals Lend Support for Individual Insurance Market Reform - Integrated Healthcare Holdings, Inc.
Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer - meetingpages.com
meetingpages.com Announces Mile-High Expansion - Microsoft Corp.
Microsoft, Penn State Hershey Medical Center Showcase Road Map to Patient Flow Efficiencies at First Healthcare Provider Symposium - Prostate Cancer
USHIFU Announces First Sonablate(R) HIFU Device in India for Minimally Invasive Prostate Cancer Treatment - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
